Clarify the Role of Tirzepatide for Type 2 Diabetes
January 2024
You’ll hear buzz about injectable tirzepatide (Mounjaro), the first “twincretin” for type 2 diabetes.
Tirzepatide is similar to glucagon-like peptide-1 (GLP-1) agonists...but it’s also a glucose-dependent insulinotropic polypeptide (GIP) agonist.
GLP-1 and GIP stimulate insulin release, increase satiety, and decrease glucose production.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive